Soares N M, Ferraz T P L, Nascimento E G, Carvalho E M, Pontes-de-Carvalho L
Centro de Pesquisa Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Microb Pathog. 2006 Jun;40(6):254-60. doi: 10.1016/j.micpath.2006.02.005. Epub 2006 Apr 19.
Opportunistic infections, due to disease-related immunosuppression, constitute the major cause of death in American visceral leishmaniasis (AVL). Sera from these patients (AVL sera) non-specifically inhibit the in vitro proliferative response of normal human lymphocytes to lectins or antigens. In the present work, the mediation of this inhibition by IgG, immune complexes and low- or very low-density lipoproteins was studied. AVL serum fractions containing proteins with the molecular weight of IgG, and IgG, purified from AVL sera by anion exchange chromatography, did not suppress the lymphoproliferation. Most of the suppressive activity of AVL sera was associated with a fraction containing molecules with molecular weights above 430 kDa. This would be compatible with it being due to immune complexes and/or lipoproteins, and not to soluble IL-2 receptors as reported previously. However, neither of the two possibilities seem to be the case, as (1) depletion of immune complexes by protein-A followed by protein-G chromatographies did not affect the serum suppressive activity, (2) no correlation between immune complex contents and suppressive activities in individual sera was observed, and (3) plasma lipoproteins (VLDL and LDL), purified from AVL patients and from healthy individuals, had the same degree of immunosuppressive activity.
由于疾病相关的免疫抑制,机会性感染是美国内脏利什曼病(AVL)的主要死因。这些患者的血清(AVL血清)非特异性抑制正常人淋巴细胞对凝集素或抗原的体外增殖反应。在本研究中,对IgG、免疫复合物以及低密度或极低密度脂蛋白介导的这种抑制作用进行了研究。含有分子量与IgG相当的蛋白质的AVL血清组分,以及通过阴离子交换色谱从AVL血清中纯化的IgG,均未抑制淋巴细胞增殖。AVL血清的大部分抑制活性与一个含有分子量大于430 kDa分子的组分相关。这与抑制作用是由免疫复合物和/或脂蛋白引起的相符,而不是如先前报道的由可溶性白细胞介素-2受体引起。然而,这两种可能性似乎都不成立,因为:(1)通过蛋白A和随后的蛋白G色谱法去除免疫复合物并不影响血清抑制活性;(2)未观察到个体血清中免疫复合物含量与抑制活性之间的相关性;(3)从AVL患者和健康个体中纯化的血浆脂蛋白(极低密度脂蛋白和低密度脂蛋白)具有相同程度的免疫抑制活性。